Tag: partnerships
-
5 Signals from HLTH Europe That Reveal Diagnostics’ Next Challenge
I attended HLTH Europe looking for signals about the future role of diagnostics in healthcare. AI dominated the agenda, but the most interesting observation was not AI itself. It was the convergence of five themes: Taken together, these conversations point to something larger than technology. Health intelligence is being built. Diagnostics is already part of…
-
Healthcare as Seen at HLTH Europe 2026
This Observation draws on HLTH Europe 2026 as a selective but useful view of where healthcare attention is moving. No conference represents the full reality of healthcare. Conferences highlight certain themes, attract particular audiences, and leave much of everyday clinical, operational, and institutional life outside the room. Even so, they can reveal where investment is…
-
HLTH Europe 2026 – Amsterdam
Is Diagnostics at the Table? HLTH Europe 2026 offers a useful test of diagnostics’ position within the wider transformation of healthcare. The programme is built around many of the questions currently shaping care delivery: artificial intelligence, interoperability, health-data infrastructure, prevention, evidence generation, clinical implementation, and the redesign of patient pathways. Diagnostics is indispensable to each…
-
MedTech Forum 2026 – Stockholm
When Competitiveness Became the Main Signal The MedTech Forum 2026 produced an unusually clear signal. Across three days of sessions and professional exchanges in Stockholm, discussions repeatedly returned to a concern extending beyond regulation alone: whether Europe can maintain the industrial conditions required to convert medical innovation into sustainable scale. MDR and IVDR remained important,…
-
health.tech global summit 2026
When Innovation Became a Partnership Question Healthcare innovation is abundant. Converting it into sustained adoption remains more difficult. That distinction became increasingly visible at health.tech global summit 2026 in Basel. Across a large and energetic gathering of startups, corporates, investors, advisors, institutional actors, and international delegations, innovation appeared in many forms: artificial intelligence, digital platforms,…
-
DxPx Europe 2026
Fast Contacts, Serious Projects, and the Search for the Right Partners DxPx Europe 2026 was my first direct exposure to this particular diagnostics, biotools, precision-medicine, and digital-health partnering environment. It was also a useful reminder that the quality of an industry event is not determined only by the speakers or the formal agenda. It depends…
-
The Book – INSIGHT 5 – Strategy in Diagnostics Is Selection Under Constraint.
The central question is not which opportunity appears most attractive. It is which exposure the organisation is prepared to inhabit. Why does this matter now? Diagnostics strategy is often presented as a search for opportunity. Which technology should be developed? Which market should be entered? Which partnership should be pursued? Which segment offers the most…